The global hospital acquired disease testing market was valued at US$0.4 bn in 2014 and is expected to grow at a CAGR of 19.9% from 2015 to 2023, to reach an estimated value of US$2.0 bn by 2023.

1. Transparency Market
Research
Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical
Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast 2015 - 2023
Global Hospital Acquired Disease Testing Market to Register a
CAGR of 19.9% 2015-2023 due to High Prevalence of HAIs
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
85 Page ReportPublished Date
24-Dec-2015
Request Sample
Press Release
Buy Now

2. Hospital Acquired Disease Testing
Market
Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and
Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
The research report includes an evaluation of the diagnostic tests performed to diagnose hospital-related infections.
Also known as nosocomial infections, hospital acquired diseases have become a growing cause of morbidity across
the world. The research report has used SWOT analysis to identify the strengths, weaknesses, opportunities, and
threats of the market. Furthermore, it also includes Porter’s five forces analysis that highlights the threat of new
entrants, the threat of substitute products or services, the bargaining power of customers (buyers), the bargaining
power of suppliers, and the intensity of competitive rivalry.
Request For Report Brochure :- http://www.transparencymarketresearch.com/sample/sample.php?
flag=B&rep_id=12791
According to the research report, the global hospital acquired disease testing market was valued at US$0.4 bn in 2014
and is likely to reach US$2.0 bn by 2023, rising at a CAGR of 19.9% from 2015 to 2023. This growth will be attributable to
the growing number of cases of nosocomial infections.
In the past few years, the high incidence of nosocomial infections has led to a high rate of morbidity. This is especially
seen amongst patients who have a weaker immune system and fall prey to poor hygiene conditions in the hospitals. The
growing pool of geriatrics is the primary reasons for the growth in the prevalence of hospital acquired diseases across the
globe.
The global hospital acquired disease testing market has been segmented on the basis of test and geography. On the
basis of test, this market is segmented into urinary tract infections, pneumonia infections, bloodstream-associated
infections, MRSA infections, surgical site infections, and others. Geographically, this market is segmented into North
America, Asia Pacific, Europe, Latin America, and the Middle East and Africa.
Of all the segments based on test type, the hospital acquired urinary tract infection diagnostics segment holds a
dominating share in the overall market due to the high prevalence of urinary infections and its impact on morbidity.
Analysts predict that this segment will continue to show its dominance in the market through 2023. Additionally, the market
for testing solutions such as surgical site infections and pneumonia (ventilator associated and hospital associated
infections) will also expand due to the high prevalence of these conditions in emerging economies in Latin America, Asia
Pacific, and other developing regions.
Transparency Market Research
2
REPORT DESCRIPTION

3. Hospital Acquired Disease Testing
Market
Some of the top players mentioned in the research report about the global hospital acquired disease testing market are
Diatherix Laboratories Inc., Qiagen GmbH, Gen-Probe Inc., L Hoffman La Roche, Cepheid, Inc., Meridian Biosciences,
Life Technologies Corporation, Nordion, Inc., and Cantel Medical Corporation. The research report also offers a detailed
explanation of the competitive landscape of the global hospital acquired disease testing market. Furthermore, it also
assesses the financial overview, research and development activities, business and marketing strategies, product
portfolio, and strategic mergers and acquisitions of these top players in the overall market.
Browse Full Report With TOC:- http://www.transparencymarketresearch.com/neurorehabilitation-devices-
market.html
Table of Contents:-
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Global Hospital Acquired Disease Testing Market Share, by Geography, 2014–2023 (US$ Mn)
2.2 Global Hospital Acquired Disease Testing Market, by Test, 2014 (US$ Mn)
2.3 Hospital Acquired Disease Testing Market Snapshot
Chapter 3 Hospital Acquired Disease Testing Market – Industry Analysis
3.1 Introduction
3.2 Market Drivers
3.2.1 Establishment of government guidelines and code for prevention of HAIs
3.2.2 Increase in prevalence of HAIs and rise in the number of drug resistant pathogens
3.3 Restraints
3.3.1 Stringent regulations and guidance framework
Transparency Market Research
3

4. Hospital Acquired Disease Testing
Market
3.3.2 Lack of controlling authorities and control programs in less developed regions
3.4 Opportunity
3.4.1 Passage of the Patient Care and Affordable Care Act in the U.S.
3.4.2 Technological development in the field of molecular diagnostics
3.5 Porter’s Five Forces Analysis
3.6 Market Attractiveness Analysis– Hospital Acquired Disease Testing Market, by Geography (2014) (Value %)
Chapter 4 Market Segmentation – By Test
4.1 Introduction
4.2 Global Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
4.2.1 Global Urinary Tract Infection Testing Market Revenue, 2013–2023 (US$ Mn)
4.2.2 Global Surgical Site Infection Testing Market Revenue, 2013–2023 (US$ Mn)
4.2.3 Global Pneumonia Infection Testing Market Revenue, 2013–2023 (US$ Mn)
4.2.4 Global Bloodstream Infection Testing Market Revenue, 2013–2023 (US$ Mn)
4.2.5 Global Others Infection Testing Market Revenue, 2013–2023 (US$ Mn)
Chapter 5 Market Segmentation – By Geography
5.1 Introduction
5.2 Global Hospital Acquired Disease Testing Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.3 North America Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.4 North America Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.5 Europe Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.6 Europe Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.7 Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.8 Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.9 Latin America Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.10 Latin America Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.11 Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
Transparency Market Research
4

5. Hospital Acquired Disease Testing
Market
5.12 Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
Chapter 6 Recommendations
Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 Alere, Inc.
7.3 Becton, Dickinson and Company
7.4 bioMérieux SA
7.5 F. Hoffmann-La Roche Ltd.
7.6 Hologic, Inc.
7.7 QIAGEN
7.8 Siemens Healthcare
7.9 Diatherix Laboratories, Inc.
7.10 Meridian Bioscience, Inc.
7.11 Thermo Fisher Scientific, Inc. (Life Technologies Corporation)
7.12 Cepheid, Inc.
Transparency Market Research is a market intelligence company providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for
thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data
sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
Transparency Market Research
5
About Us
Contact

6. Hospital Acquired Disease Testing
Market
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Transparency Market Research
6